Journal of Hepatology
Volume 33, Issue 3 , Pages 487-496 , September 2000

EASL International Consensus Conference on Haemochromatosis: Part II. Expert Document

  • Paul Adams ((Expert Group Co-ordinators))

      Affiliations

    • University of Western Ontario, London, Ontario, Canada
    • ,
  • Pierre Brissot ((Expert Group Co-ordinators))

      Affiliations

    • Clinique des Maladies du Foie et Unité INSERM U-522 Hôpital Pontchaillou, Rennes, France
    • ,
  • Lawrie W. Powell ((Expert Group Co-ordinators))

      Affiliations

    • Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland4029 Australia

References 

  1. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and haemochromatosis: at the crossroads. Gastroenterology. 1999;116:193–207
  2. Pietrangelo A. Haemochromatosis 1998: is one gene enough?. J Hepatol. 1998;29:502–509
  3. Bacon BR, Rebholz AE, Fried M, Di Bisceglie AM. Beneficial effect of iron reduction therapy in patients with chronic hepatitis C who failed to respond to interferon-α. Hepatology. 1993;18:150A
  4. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early haemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 1986;6:24–29
  5. Bothwell TH, Charlton RW, Motulsky AG. Haemochromatosis. In:  Scriver CR,  Beaudet AL,  Sly WS,  Valle D editor. The Metabolic and Molecular Basics of Inherited Disease, 7th ed.. New York: McGaw-Hill; 1995;p. 2237–2269
  6. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava E. A novel MHC class-I like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408
  7. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, et al.  Haemochromatosis and HLA-H. Nat Genet. 1996;14:249–251
  8. Merryweather-Clarke AT, Pointon JJ, Sherman JD, Robson KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997;34:275–278
  9. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, et al.  Mutation analysis of the HLA-H gene in Italian haemochromatosis patients. Am J Hum Genet. 1997;60:828–832
  10. Sheldon JH. In: Haemochromatosis. London: Oxford University Press; 1935;p. 382
  11. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary haemochromatosis. Gastroenterology. 1996;110:1107–1119
  12. Adams PC, Kertesz AE, Valberg LS. Clinical presentation of haemochromatosis: a changing scene. Am J Med. 1991;90:445–449
  13. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic haemochromatosis in women compared to men. Ann Intern Med. 1997;127:105–110
  14. Bacon BR, Sadiq SA. Hereditary haemochromatosis: presentation and diagnosis in the 1990s. Am J Gastroenterol. 1997;92:784–789
  15. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic haemochromatosis. Hepatology. 1997;25:162–166
  16. Miller M, Hutchins GM. Haemochromatosis, multiorgan hemosiderosis, and coronary artery disease. JAMA. 1994;272:231–233
  17. Bomford A, Williams R. Long term results of venesection therapy in idiopathic haemochromatosis. Q J Med. 1976;45:611–623
  18. Bradbear RA, Bain C, Siskind V, Schofield FD, Webb S, Axelsel EM, et al.  Cohort study of internal malignancy in genetic haemochromatosis and other chronic non-alcoholic liver diseases. J Nat Cancer Inst. 1985;75:81–84
  19. Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, et al.  Survival and prognostic factors in 212 Italian patients with genetic haemochromatosis. Hepatology. 1992;15:655–659
  20. Yang Q, McDonnell S, Khoury M, Cono J, Parrish R. Haemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data. Ann Intern Med. 1998;129:946–953
  21. Fargion S, Fracanzani AL, Piperno A, Braga M, D'Alba R, Ronchi G, et al.  Prognostic factors for hepatocellular carcinoma in genetic haemochromatosis. Hepatology. 1994;20:1426, ??
  22. George DK, Fletcher LM, Monk CD, Walker NI, Do KA, Powell LW. Is hepatic iron cause of raised serum transaminases in haemochromatosis?. Hepatology. 1998;28:421A
  23. Cecchetti G, Binda A, Piperno A, Nador F, Fargion S, Fiorelli G. Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: polygraphic and echocardiographic evaluation. Eur Heart J. 1991;12:224–230
  24. Deugnier Y, Loréal O, Turlin B, Guyader D, Jouanolle H, Moirand R, et al.  Liver pathology in genetic haemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology. 1992;102:2050–2059
  25. Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J, et al.  Noninvasive prediction of fibrosis in C282Y homozygous haemochromatosis. Gastroenterology. 1998;115:929–936
  26. Fracanzani AL, Fargion S, Romano R, Conte D, Piperno A, D'Alba R, et al.  Portal hypertension and iron depletion in patients with genetic haemochromatosis. Hepatology. 1995;22:1127–1131
  27. Trousseau A. In: Leçon de Clinique Médicale de l'Hotel-Dieu. Paris: Baillère; 1865;p. 663–693
  28. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary haemochromatosis. Gastroenterology. 1991;101:368–372
  29. Barton JC, Barton NH, Alford TJ. Diagnosis of hemochromatosis probands in a community hospital. Am J Med. 1997;103:498–503
  30. Niederau C, Niederau CM, Lange S, Littauer A, Abdel-Jalil N, Maurer M, et al.  Screening for haemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med. 1998;128:337–345
  31. Phatak P, Sham R, Rabuertas R, Dunnigan K, O'Leary M, Braggins C, et al.  Prevalence of hereditary haemochromatosis in a sample of 16,031 primary care patients. Ann Intern Med. 1998;129:954–961
  32. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of haemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988;318:1355–1362
  33. Baer DM, Simons JL, Staples RL, Rumore GJ, Morton CJ. Haemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med. 1995;98:464–468
  34. Smith BN, Kantrowitz W, Grace ND, Greenberg MS, Patton TJ, Ookubo R, et al.  Prevalence of hereditary haemochromatosis in a Massachusetts corporation: is Celtic origin a risk factor?. Hepatology. 1997;25:1439–1446
  35. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic haemochromatosis: evolution of diagnostic criteria. Gastroenterology. 1998;114:319–323
  36. McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer-Strawn L. Population-based screening for haemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med. 1999;107:30–37
  37. Adams PC, Kertesz AE, McLaren C, Barr R, Bamford A, Chakrabarti S. Population screening for haemochromatosis: a comparison of unbound iron binding capacity, transferrin saturation and C282Y genotyping in 5,211 voluntary blood donors. [abstract] Hepatology. 1999; in press
  38. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, et al.  Heterogeneity of haemochromatosis in Italy. Gastroenterology. 1998;114:996–1002
  39. Lucotte G. Celtic origin of the C282Y mutation of haemochromatosis. Blood Cells Mol Dis. 1998;24:433–438
  40. Ryan E, O'Keane C, Crowe J. Haemochromatosis in Ireland and HFE. Blood Cells Mol Dis. 1998;24:428–432
  41. Wurapa RK, Gordeuk V, Brittenham G, Khiyami A, Schechter GP, Edwards CQ. Primary iron overload in African Americans. Am J Med. 1996;100:9–18
  42. Gordeuk V, Mukiibi J, Hasstedt SJ, Samowitz W, Edwards CQ, West G, et al.  Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med. 1992;326:95–100
  43. Adams PC, Valberg LS. Screening blood donors for hereditary haemochromatosis: decision analysis model comparing genotyping to phenotyping. Am J Gastroenterol. 1999;94:1593–1600
  44. Phatak PD, Guzman G, Woll JE, Robeson A, Phelps CE. Costeffectiveness of screening for hereditary haemochromatosis. Arch Intern Med. 1994;154:769–776
  45. Tavill AS. Screening for haemochromatosis: phenotyping or genotyping or both?. Am J Gastroenterol. 1999;94:1430–1433
  46. Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary haemochromatosis: decision analysis model based on a thirty-year database. Gastroenterology. 1995;109:177–188
  47. Olynyk J, Cullen D, Rossi R, Summerville L, Powell LW. A population based study of the clinical expression of the haemochromatosis gene. N Engl J Med. 1999;341:718–724
  48. Jeffrey G, Chakrabarti S, Hegele R, Adams PC. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nat Genet. 1999;22:325–326
  49. Somerville M, Sprysak K, Hicks M, Elyas B, Vichen-Wyhony L. An HFE intronic variant promotes misdiagnosis of hereditary haemochromatosis. Am J Hum Genet. 1999;65:924–926
  50. Willis G, Winperis J, Smith K, Fellows I, Jennings B. Haemochromatosis gene C282Y homozygotes in an elderly male population. Lancet. 1999;354:221–222
  51. Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen. 1996;3:178–184
  52. Cogswell M, Burke W, McDonnell S, Franks A. Screening for haemochromatosis. A public health perspective. Am J Prev Med. 1999;16:134–140

☆ Co-sponsored by the World Health Organization∗ Supported by the National Institutes of Health and the Centers for Disease Control and Prevention (USA)

☆☆ This document summarises the discussion and the conclusions reached by the three different expert groups1 engaged in the consensus conference

PII: S0168-8278(01)80874-6

Journal of Hepatology
Volume 33, Issue 3 , Pages 487-496 , September 2000

Article Tools